Biomedicines | Editor’s Choice Articles Published in 2023–2024 in the “Gene and Cell Therapy” Section
We are pleased to announce the selection of the Editor’s Choice Articles published in Biomedicines (ISSN: 2227-9059, latest Impact Factor 3.9, CiteScore 6.8) in the “Gene and Cell Therapy” Section. All of these papers have been selected by the Editorial Board Members from 2023 to 2024 and have been positively received by researchers; therefore, it is believed that they will interest readers and provide opportunities for follow-up research.
1. “SERPINA3: Stimulator or Inhibitor of Pathological Changes”
by Mateusz de Mezer, Jan Rogaliński, Stanisław Przewoźny, Michał Chojnicki, Leszek Niepolski, Magdalena Sobieska and Agnieszka Przystańska
Biomedicines 2023, 11(1), 156; https://doi.org/10.3390/biomedicines11010156
Available online: https://www.mdpi.com/2227-9059/11/1/156
2. “Adipose Tissue and Adipose-Tissue-Derived Cell Therapies for the Treatment of the Face and Hands of Patients Suffering from Systemic Sclerosis”
by Anouck Coulange Zavarro, Mélanie Velier, Robin Arcani, Maxime Abellan Lopez, Stéphanie Simoncini, Audrey Benyamine, Quentin Gomes De Pinho, Raphael Coatmeur, Jiucun Wang, Jingjing Xia et al.
Biomedicines 2023, 11(2), 348; https://doi.org/10.3390/biomedicines11020348
Available online: https://www.mdpi.com/2227-9059/11/2/348
3. “The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells”
by Agnieszka Kulesza, Agnieszka Kulesza and Anna Burdzinska
Biomedicines 2023, 11(2), 445; https://doi.org/10.3390/biomedicines11020445
Available online: https://www.mdpi.com/2227-9059/11/2/445
4. “3D Spheroid Cultivation Alters the Extent and Progression of Osteogenic Differentiation of Mesenchymal Stem/Stromal Cells Compared to 2D Cultivation”
by Anne Wolff, Marcus Frank, Susanne Staehlke, Armin Springer, Olga Hahn, Juliane Meyer and Kirsten Peters
Biomedicines 2023, 11(4), 1049; https://doi.org/10.3390/biomedicines11041049
Available online: https://www.mdpi.com/2227-9059/11/4/1049
5. “Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System”
by Julie Carrard, Fiona Ratajczak, Joséphine Elsens, Catherine Leroy, Rebekah Kong, Lucie Geoffroy, Arnaud Comte, Guy Fournet, Benoît Joseph, Xiubin Li et al.
Biomedicines 2023, 11(10), 2801; https://doi.org/10.3390/biomedicines11102801
Available online: https://www.mdpi.com/2227-9059/11/10/2801
6. “Suppressing Pro-Apoptotic Proteins by siRNA in Corneal Endothelial Cells Protects against Cell Death”
by Susanne Staehlke, Siddharth Mahajan, Daniel Thieme, Peter Trosan and Thomas A Fuchsluger
Biomedicines 2024, 12(7), 1439; https://doi.org/10.3390/biomedicines12071439
Available online: https://www.mdpi.com/2227-9059/12/7/1439
7. “Restoration of T and B Cell Differentiation after RAG1 Gene Transfer in Human RAG1 Defective Hematopoietic Stem Cells”
by Nataël Sorel, Francisco Díaz-Pascual, Boris Bessot, Hanem Sadek, Chloé Mollet, Myriam Chouteau, Marco Zahn, Irene Gil-Farina, Parisa Tajer, Marja van Eggermond et al.
Biomedicines 2024, 12(7), 1495; https://doi.org/10.3390/biomedicines12071495
Available online: https://www.mdpi.com/2227-9059/12/7/1495
8. “Cell-Based Treatment in Acute Myeloid Leukemia Relapsed after Allogeneic Stem Cell Transplantation”
by Martina Canichella and Paolo de Fabritiis
Biomedicines 2024, 12(8), 1721; https://doi.org/10.3390/biomedicines12081721
Available online: https://www.mdpi.com/2227-9059/12/8/1721
9. “Updates on Chimeric Antigen Receptor T-Cells in Large B-Cell Lymphoma”
by Khalil Saleh, Nadine Khalife, Ahmadreza Arbab, Rita Khoury, Claude Chahine, Rebecca Ibrahim, Zamzam Tikriti, Nohad Masri, Mohamad Hachem and Axel Le Cesne
Biomedicines 2024, 12(12), 2810; https://doi.org/10.3390/biomedicines12122810
Available online: https://www.mdpi.com/2227-9059/12/12/2810
To acknowledge the above authors’ excellent contribution, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:
Submitting a manuscript:
The “Gene and Cell Therapy” Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.
Joining the Volunteer Reviewer Board:
If you are an active researcher in the fields of biomedicincal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.
Biomedicines Editorial Office